PetCaseFinder

Peer-reviewed veterinary case report

Test to detect autoimmune antibodies in dogs with pemphigus

By Nishifuji, Koji et al.·Published in Veterinary dermatology·2009·Department of Veterinary Medicine, Japan·View original on PubMed

PetCaseFinder translated the abstract of this peer-reviewed paper into plain English so pet owners can read it. We do not publish original research — every detail traces back to the citation above. How we work →

Original publication title: Development of an enzyme-linked immunosorbent assay for detection of circulating IgG autoantibodies against canine desmoglein 3 in dogs with pemphigus.

Species:
dog
Skin & coatDogs

Plain-English summary

A group of dogs with pemphigus, an autoimmune skin disease that causes painful blisters, was tested for specific antibodies in their blood. Researchers developed a test that could detect these antibodies against a protein called desmoglein 3, which is important for skin cell adhesion. The test showed that most dogs with pemphigus vulgaris had high levels of these antibodies, while healthy dogs and those with other skin conditions did not. This new test could help veterinarians quickly identify dogs with pemphigus and start appropriate treatment sooner.

People also search for: dog pemphigus symptoms · autoimmune skin disease in dogs · dog skin blisters treatment

Abstract

Pemphigus, a group of autoimmune blistering dermatoses recognized in humans and dogs, is divided into three subgroups: pemphigus vulgaris (PV), pemphigus foliaceus (PF) and paraneoplastic pemphigus (PNP). Previously, we have demonstrated that circulating anti-desmoglein 3 (Dsg3) IgG in dogs with PV and PNP disrupts Dsg3-mediated keratinocyte cell-cell adhesion. The aim of this study was to develop an enzyme-linked immunosorbent assay (ELISA) for the detection of circulating IgG against canine Dsg3 in dogs with pemphigus. A secreted form of recombinant protein representing the entire extracellular domain of canine Dsg3 (cDsg3) was produced by baculovirus expression and used as the coated antigen in the ELISA. The titre of anti-cDsg3 ELISA was significantly higher in canine PV (n = 14) than that in healthy dogs (n = 44) (P < 0.05). Of the canine PV and PNP sera, 11/14 (79%) canine PV sera and the canine PNP serum were positive in the anti-cDsg3 ELISA. On the other hand, 14/37 (38%) sera from canine PF and 9/18 (50%) sera from canine autoimmune subepidermal bullous dermatoses were positive in the ELISA. Circulating IgG against cDsg3 was not recognized in dogs with superficial pyoderma (n = 5), atopic dermatitis (n = 8), or in healthy dogs (n = 44). Moreover, IgG immunoreactivity against cDsg3 in all 21 sera was completely absorbed by preincubation with cDsg3. These findings altogether suggest that the anti-cDsg3 ELISA can be used as a rapid screening test for the detection of circulating anti-Dsg3 IgG autoantibodies in canine pemphigus.

Find similar cases for your pet

PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.

Search related cases →

Original publication on PubMed: https://pubmed.ncbi.nlm.nih.gov/20178469/